UCSD researcher wins grant to study colon cancer in African-Americans

The California Cancer Research Program (CRP) of the state Department of Health Services has awarded a physician-scientist at University of California, San Diego (UCSD) a $600,000 grant to conduct a 3-year study of colon cancer in African-Americans.

John Carethers, M.D., assistant professor of medicine at UCSD School of Medicine and member of the UCSD Cancer Center, received the highest score possible in the granting process. There were 92 grants funded out of 302 applications submitted.

With this grant, Carethers and colleagues will study tissue samples from African-American colon cancer patients to determine the incidence and impact of a particular chromosomal abnormality, called microsatellite instability (MSI). This abnormality is associated with colorectal cancer development, particularly the more virulent types. African-Americans seem to suffer from a more aggressive form of the disease compared to whites.

"When compared to statistics for whites, African-Americans have only a slightly higher incidence of colorectal cancer, but they have much higher death rates," said Carethers. "We believe MSI may play an important role."

Preliminary research in Carethers' laboratory has shown that cells with this abnormality do not respond to the widely used chemotherapeutic agent 5-fluoruracil (5-FU). The researchers will now further test this observation by studying the medical records of patients who received 5-FU treatment and whose tissue tested positive for microsatellite instability.

Also, the team will study the genes mutated by microsatellite instability to determine if they might be useful in predicting a given tumor's potential for metastasis.

"The new insights gained from this work may reveal the need for new screening strategies and new chemotherapeutic agents," said Carethers. "In addition, we hope to gain a clearer understanding of tumor formation that will benefit all patients."

Every year, approximately 149,000 people in

Contact: Nancy Stringer
University of California - San Diego

Page: 1 2

Related medicine news :

1. U of M researcher says Viagra may cause permanent vision loss in some men
2. Indiana University researchers closer to helping hearing-impaired using stem cells
3. Protein that helps skin cancer spread identified by Stanford researchers
4. US life expectancy about to decline, researchers say
5. Gene for age-related macular degeneration discovered by Yale researchers
6. Dartmouth researchers find where musical memories are stored in the brain
7. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
8. US cancer researchers launch first American-Israeli cancer conference
9. Mayo Clinic researcher calls for improved newborn screening
10. Hard choices: Pitt researcher presents findings on when to accept organ transplants
11. Brain-scanning technologies need standards, according to Stanford researcher

Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology:
Cached News: